Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TBI: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TBI is a concept in neurodegeneration research. Key relationships include: co discussed, associated with, inhibits. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 74 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | TBI |
| Key Genes/Proteins | AKT |
| Related Diseases | ALS, ALZHEIMER, alzheimers, ALZHEIMER'S, ALZHEIMER'S DISEASE |
Knowledge base pages for this entity
graph TD
TBI["TBI"]
TBI -->|"regulates"| BRAIN["BRAIN"]
TBI -->|"causes"| neuroinflammation["neuroinflammation"]
TBI -->|"inhibits"| autophagy["autophagy"]
TBI -->|"causes"| neuroinflammatory_responses["neuroinflammatory responses"]
NEUROPROTEOMICS["NEUROPROTEOMICS"] -->|"investigates"| TBI
AGING["AGING"] -->|"causes"| TBI
NEURON["NEURON"] -->|"interacts"| TBI
INFLAMMATION["INFLAMMATION"] -->|"regulates"| TBI
MICROGLIA["MICROGLIA"] -->|"regulates"| TBI
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"regulates"| TBI
RIPK1["RIPK1"] -->|"treats"| TBI
RIPK3["RIPK3"] -->|"treats"| TBI
APOPTOSIS["APOPTOSIS"] -->|"causes"| TBI| Target | Relation | Type | Str |
|---|---|---|---|
| alzheimers | increases_risk | disease | 0.95 |
| BRAIN | regulates | brain_region | 0.72 |
| neuroinflammation | causes | process | 0.70 |
| autophagy | inhibits | pathway | 0.70 |
| neuroinflammatory responses | causes | process | 0.70 |
| TRAUMATIC BRAIN INJURY | causes | disease | 0.65 |
| TRAUMATIC BRAIN INJURY | interacts_with | disease | 0.65 |
| TRAUMATIC BRAIN INJURY | impairs | disease | 0.65 |
| TRAUMATIC BRAIN INJURY | promotes | disease | 0.65 |
| TRAUMATIC BRAIN INJURY | contributes_to | disease | 0.65 |
| TNF | activates | gene | 0.60 |
| TUMOR | activates | disease | 0.60 |
| TH | activates | gene | 0.60 |
| TLR4 | mediates | gene | 0.60 |
| TREM2 | activates | gene | 0.60 |
| WHITE MATTER | contributes_to | brain_region | 0.60 |
| TDP-43 | co_discussed | entity | 0.50 |
| TLR4 | co_discussed | entity | 0.50 |
| APOPTOSIS | activates | process | 0.50 |
| TAU | causes | entity | 0.50 |
| THALAMUS | co_discussed | entity | 0.50 |
| NEUROINFLAMMATION | activates | process | 0.50 |
| PYROPTOSIS | activates | process | 0.50 |
| ULK1 | co_discussed | entity | 0.50 |
| VEGF | co_discussed | entity | 0.50 |
| TNF | co_discussed | entity | 0.50 |
| WHITE MATTER | co_discussed | entity | 0.50 |
| APOPTOSIS | inhibits | process | 0.50 |
| NEUROINFLAMMATION | regulates | process | 0.50 |
| NEURODEGENERATION | associated_with | process | 0.50 |
| NEUROINFLAMMATION | associated_with | process | 0.50 |
| APOPTOSIS | associated_with | process | 0.50 |
| FERROPTOSIS | associated_with | process | 0.50 |
| NECROPTOSIS | associated_with | process | 0.50 |
| PYROPTOSIS | associated_with | process | 0.50 |
| OXIDATIVE STRESS | inhibits | process | 0.50 |
| NEURODEGENERATION | causes | process | 0.50 |
| REMYELINATION | involved_in | process | 0.50 |
| AGING | activates | process | 0.50 |
| TFEB | co_discussed | entity | 0.50 |
| DEPRESSION | regulates | disease | 0.50 |
| OXIDATIVE STRESS | regulates | process | 0.50 |
| TREM2 | co_discussed | gene | 0.40 |
| TUMOR | co_discussed | disease | 0.40 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| MICROGLIA | associated_with | cell_type | 0.90 |
| PARKINSON'S DISEASE | associated_with | disease | 0.90 |
| 19371326 | promotes | paper | 0.90 |
| 36183712 | is associated with increased risk of | paper | 0.90 |
| ASTROCYTES | associated_with | cell_type | 0.74 |
| NF-KB | associated_with | protein | 0.74 |
| ALS | associated_with | disease | 0.74 |
| NEUROPROTEOMICS | investigates | pathway | 0.72 |
| MICROGLIA | activates | cell_type | 0.66 |
| AKT | associated_with | gene | 0.66 |
| ANXIETY | associated_with | disease | 0.65 |
| NEURON | expressed_in | cell_type | 0.65 |
| HMGB1 | expressed_in | gene | 0.65 |
| NEURON | reduces | cell_type | 0.65 |
| NEURONS | interacts_with | cell_type | 0.60 |
| NEURON | exacerbates | cell_type | 0.60 |
| NLRP3 | mediates | gene | 0.60 |
| MICROGLIA | protects_against | cell_type | 0.60 |
| NEUTROPHIL | associated_with | cell_type | 0.60 |
| NEUTROPHIL | causes | cell_type | 0.60 |
| NEURONS | protects_against | cell_type | 0.60 |
| NEUTROPHIL | mediates | cell_type | 0.60 |
| T CELL | protects_against | cell_type | 0.60 |
| NEURON | protects_against | cell_type | 0.60 |
| ASTROCYTE | interacts_with | cell_type | 0.60 |
| ASTROCYTES | interacts_with | cell_type | 0.60 |
| CORTEX | interacts_with | brain_region | 0.60 |
| 22285252 | may induce | paper | 0.60 |
| 20145419 | may lead to an increase in | paper | 0.60 |
| NEURON | interacts_with | cell_type | 0.60 |
| RIPK1 | treats | gene | 0.60 |
| RIPK3 | treats | gene | 0.60 |
| ALZHEIMER'S | associated_with | disease | 0.60 |
| NEURON | causes | cell_type | 0.60 |
| NEURON | regulates | cell_type | 0.60 |
| ALZHEIMER | associated_with | disease | 0.60 |
| MICROGLIA | mediates | cell_type | 0.60 |
| NEURON | inhibits | cell_type | 0.60 |
| NEURONS | inhibits | cell_type | 0.60 |
| DEPRESSION | associated_with | disease | 0.60 |
| MICROGLIA | regulates | cell_type | 0.58 |
| NEURODEGENERATION | causes | disease | 0.58 |
| MTOR | associated_with | gene | 0.56 |
| NLRP3 | co_discussed | entity | 0.50 |
| ASTROCYTE | co_discussed | entity | 0.50 |
| ASTROCYTES | co_discussed | entity | 0.50 |
| FERROPTOSIS | co_discussed | entity | 0.50 |
| OLIGODENDROCYTE | co_discussed | entity | 0.50 |
| OLIGODENDROCYTES | co_discussed | entity | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Traumatic Brain Injury and Alzheimer's Disease Relationship | validation | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe | clinical | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $200,000 |
| Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe | clinical | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $180,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning TBI in their description or question text
No additional research found